Moleculin Biotech, Inc.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-6.0M | $-6.4M | $-10.3M | $-5.6M | $-6.0M | $-7.9M | $-6.8M | $-8.6M |
| Depreciation & Amortization | $31.0K | $32.0K | $34.0K | $32.0K | $31.0K | $30.0K | $32.0K | $32.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $453.0K | $493.0K | $479.0K | $493.0K | $513.0K | $499.0K | $535.0K | $699.0K |
| Net Cash from Operating Activities | $-5.9M | $-6.7M | $-4.9M | $-7.6M | $-5.1M | $-6.0M | $-7.3M | $-7.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $13.0K | $0 | $81.0K | $28.0K | $15.0K | $0 | $0 | $0 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-13.0K | $0 | $-81.0K | $-28.0K | $-15.0K | $0 | $0 | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-25.0K | $0 | $4.0M | $-4.0K | $49.0K | $141.0K | $0 | $-11.0K |
| Net Change in Cash | $-6.0M | $-6.7M | $-1.0M | $-7.6M | $-5.1M | $-5.9M | $-7.2M | $-7.6M |
| Free Cash Flow | $-6.0M | $-6.7M | $-5.0M | $-7.6M | $-5.1M | $-6.0M | $-7.3M | $-7.6M |